Gary L. Clayman

22.2k total citations · 1 hit paper
232 papers, 13.8k citations indexed

About

Gary L. Clayman is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Gary L. Clayman has authored 232 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 67 papers in Surgery and 62 papers in Molecular Biology. Recurrent topics in Gary L. Clayman's work include Head and Neck Cancer Studies (45 papers), Thyroid Cancer Diagnosis and Treatment (45 papers) and Cancer-related Molecular Pathways (39 papers). Gary L. Clayman is often cited by papers focused on Head and Neck Cancer Studies (45 papers), Thyroid Cancer Diagnosis and Treatment (45 papers) and Cancer-related Molecular Pathways (39 papers). Gary L. Clayman collaborates with scholars based in United States, Japan and Italy. Gary L. Clayman's co-authors include Adel K. El‐Naggar, Helmuth Goepfert, Ying C. Henderson, Scott M. Lippman, Mitchell J. Frederick, Waun Ki Hong, Arumugam Jayakumar, David Sidransky, J. Jack Lee and Steven Piantadosi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Gary L. Clayman

230 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic progression model for head and neck cancer: implications for field cancerization.

1996 1.1k citations Gary L. Clayman, David Sidransky et al. PubMed profile →

Peers

Countries citing papers authored by Gary L. Clayman

Since Specialization

Citations

This map shows the geographic impact of Gary L. Clayman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. Clayman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. Clayman more than expected).

Fields of papers citing papers by Gary L. Clayman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. Clayman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. Clayman. The network helps show where Gary L. Clayman may publish in the future.

Co-authorship network of co-authors of Gary L. Clayman

This figure shows the co-authorship network connecting the top 25 collaborators of Gary L. Clayman. A scholar is included among the top collaborators of Gary L. Clayman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary L. Clayman. Gary L. Clayman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies 2019 ·Clinical Cancer Research ·Iñigo Landa, Nikita Pozdeyev, Christopher Korch, Laura A. Marlow, Robert C. Smallridge, John A. Copland, Ying C. Henderson, Stephen Y. Lai, Gary L. Clayman, Naoyoshi Onoda, Aik Choon Tan, María E.R. García-Rendueles, Jeffrey A. Knauf, Bryan R. Haugen, James A. Fagin, Rebecca E. Schweppe	130
2	88 ^th Annual Meeting of the American Thyroid Association 2018 ·Thyroid ·Gary L. Clayman, Ian D. Hay, Mimi I. Hu, Lori J. Wirth, (unknown), (unknown), (unknown), George J. Kahaly, Raymond S. Douglas, Robert J. Holt, (unknown), Julie Ball, Terry J. Smith, Seong‐Keun Yoo, Yoo Sung Song, Yongjung Park	6
3	Management of the central compartment in differentiated thyroid carcinoma 2017 ·European Journal of Surgical Oncology ·Ryan P. Goepfert, Gary L. Clayman	5
4	Long-Term Outcomes of Lateral Neck Dissection in Patients with Recurrent or Persistent Well-Differentiated Thyroid Cancer 2017 ·Thyroid ·Steven B. Chinn, Mark Zafereo, Steven G. Waguespack, Beth S. Edeiken, Dianna Roberts, Gary L. Clayman	16
5	Palliative Sternal Resection for Advanced Thyroid Carcinoma 2015 ·DergiPark (Istanbul University) ·Ömer Soysal, Mustafa Şahi̇n, Joe B. Putnam, Gary L. Clayman	0
6	Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites 2011 ·Clinical Cancer Research ·Mei Zhao, Daisuke Sano, Curtis R. Pickering, Samar A. Jasser, Ying C. Henderson, Gary L. Clayman, Erich M. Sturgis, Thomas J. Ow, Reuben Lotan, Thomas E. Carey, Peter G. Sacks, Jennifer R. Grandis, David Sidransky, (unknown), Jeffrey N. Myers	224
7	Atlas of head & neck surgery 2011 ·Elsevier eBooks ·(unknown), Gary L. Clayman	7
8	An Orthotopic Model of Papillary Thyroid Carcinoma in Athymic Nude Mice 2008 ·Archives of Otolaryngology - Head and Neck Surgery ·Soon‐Hyun Ahn, Ying C. Henderson, Ya’an Kang, Chandrani Chattopadhyay, (unknown), Mary Wang, Katrina Briggs, Gary L. Clayman	41
9	Repair Capacity for UV Light–Induced DNA Damage Associated with Risk of Nonmelanoma Skin Cancer and Tumor Progression 2007 ·Clinical Cancer Research ·Li‐E Wang, Chunying Li, Sara S. Strom, Leonard H. Goldberg, Abenaa M. Brewster, Zhaozheng Guo, Yawei Qiao, Gary L. Clayman, J. Jack Lee, Adel K. El‐Naggar, Víctor G. Prieto, Madeleine Duvic, Scott M. Lippman, Randal S. Weber, Margaret L. Kripke, Qingyi Wei	37
10	4-Nitroquinoline-1-Oxide-Induced Mutagen Sensitivity and Risk of Nonmelanoma Skin Cancer: A Case–Control Analysis 2006 ·Journal of Investigative Dermatology ·Li‐E Wang, Tsai‐Ching Hsu, Ping Xiong, Sara S. Strom, Madeleine Duvic, Gary L. Clayman, Randal S. Weber, Scott M. Lippman, Leonard H. Goldberg, Qingyi Wei	15
11	Human LBP-32/MGR is a Repressor of the P450scc in Human Choriocarcinoma Cell Line JEG-3 2006 ·Placenta ·Ying C. Henderson, Mitchell J. Frederick, Arumugam Jayakumar, Yongmun Choi, (unknown), Ya’an Kang, Randall Evans, Paul M. Spring, Motonari Uesugi, Gary L. Clayman	12
12	Human Tracheal Reconstruction With a Composite Radial Forearm Free Flap and Prosthesis 2006 ·The Annals of Thoracic Surgery ·Peirong Yu, Gary L. Clayman, Garrett L. Walsh	46
13	BRAK/CXCL14 Is a Potent Inhibitor of Angiogenesis and a Chemotactic Factor for Immature Dendritic Cells 2004 ·Cancer Research ·Thomas D. Shellenberger, Mary Wang, (unknown), Arumugam Jayakumar, Robert M. Strieter, Marie D. Burdick, Constantin G. Ioannides, (unknown), Adel K. El‐Naggar, Dianna Roberts, Gary L. Clayman, Mitchell J. Frederick	204
14	SPINK5 and Netherton Syndrome: Novel Mutations, Demonstration of Missing LEKTI, and Differential Expression of Transglutaminases 2004 ·Journal of Investigative Dermatology ·Michael Raghunath, (unknown), Vinzenz Oji, Karin Aufenvenne, (unknown), Arumugam Jayakumar, Hartmut Ständer, Josef Smolle, Gary L. Clayman, Heiko Traupe	82
15	p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. 2003 ·PubMed ·Svetlana Bolshakov, Christopher M. Walker, Sara S. Strom, Mano Selvan, Gary L. Clayman, Adel K. El‐Naggar, Scott M. Lippman, Margaret L. Kripke, Honnavara N. Ananthaswamy	96
16	Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. 2000 ·PubMed ·Madeleine Duvic, (unknown), Claudia Schulz, (unknown), (unknown), C Hager, (unknown), P Hazarika, Bettie S. Jackson, Joan Breuer-McHam, Jim Young, Gary L. Clayman, S. M. Lippman, (unknown), Nancy Robinson, Anne Deucher, Richard L. Eckert, Sunil Nagpal	60
17	Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. 1998 ·PubMed ·Douglas K. Frank, Ta Jen Liu, Mitchell J. Frederick, Gary L. Clayman	11
18	Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma. 1997 ·PubMed ·Weiya Xia, (unknown), (unknown), (unknown), Lei Li, Nobutaka Kiyokawa, Gary L. Clayman, Ruth L. Katz, Mien‐Chie Hung	127
19	p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. 1995 ·PubMed ·Sagarika Kanjilal, Sara S. Strom, Gary L. Clayman, (unknown), A. K. El-Naggar, Vivek Kapur, Kathleen K. Cummings, (unknown), M. R. Spitz, Margaret L. Kripke	121
20	Combination interleukin-2 and interferon-alpha in head and neck cancer 1991 ·Stimson P. Schantz, Gary L. Clayman, Isaiah W. Dimery, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact